Role of contrast-enhanced color Doppler ultrasonography and dynamic flow in the evaluation of hepatic tumors treated with radiofrequency

Cancer Imaging

Volumn 5, Issue 1, 2005, Pages 39-45

  Lassau, N ^a   Lamuraglia, M ^a,b   Chawi, I ^a   Smayra, T ^a   Dromain, C ^a   Koscielny, S ^a   De Baere, T ^a   Leclere J ^a   Roche, A ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Contrast media; Doppler studies; Hepatic tumors; Magnetic resonance; Radiofrequency ablation; Ultrasound

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CATHETER ABLATION; COLOR ULTRASOUND FLOWMETRY; ECHOGRAPHY; FEMALE; HUMAN; LIVER TUMOR; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY;

ADULT; AGED; CATHETER ABLATION; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33645253989     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2005.0011     Document Type: Article

References (22)

1. Solbiati L, Livraghi T, Goldberg SN et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 22: 159-66.
2. McGhana JP, Dodd III GD. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 2001; 176: 3-16.
3. Morimoto M, Sugimori K, Shirato K et al. Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods. Hepatology 2002; 35: 1467-75.
4. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174: 323-30.
5. Dromain C, de Baere T, Elias D et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 2002; 223: 255-62.
6. Chopra S, Dodd III GD, Chintapalli KN, Leyendecker JR, Karahan OI, Rhim H. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dualphase contrast-enhanced CT. AJR Am J Roentgenol 2001; 177: 381-7.
7. Choi D, Lim HK, Kim SH et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000; 217: 558-63.
8. Ding H, Kudo M, Onda H et al. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001; 221: 721-30.
9. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000; 88: 2452-63.
10. Solbiati L, Goldberg SN, Ierace T, Dellanoce M, Livraghi T, Gazelle GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent-early experience. Radiology 1999; 211: 643-9.
11. Lassau N, Koscielny S, Avril MF et al. Prognostic value of angiogenesis evaluated with color Doppler high-frequency ultrasound for pre-operative assessment of melanomas. AJR Am J Roentgenol 2002; 178: 1547-51.
12. Henri P, Tranquart F. B-flow ultrasonographic imaging of circulating blood. J Radiol 2000; 81: 465-7.
13. Sato T. Technological description of dynamic flow. Toshiba Medical Review (Japanese edition) 2001; 80: 29-33.
14. Koito K, Sato T. Contrast ultrasonography using dynamic flow-clinical usefulness in the evaluation of hepatobiliary and pancreatic diseases. Toshiba Medical Review (Japanese edition) 2001; 81: 30-8.
15. Lassau N, Koscielny S, Opolon P et al. Evaluation of contrastenhanced color Doppler ultrasound for the quantification of angiogenenis in vivo. Invest Radiol 2001; 36: 50-5.
16. WHO. Handbook for reporting results of cancer treatment, Geneva, Switzerland: World Health Organization Offset Publication, 1979: 48.
17. Liu JB, Goldberg BB, Merton DA, Rawool NM, Needleman L, Forsberg F. The role of contrast-enhanced sonography for radiofrequency ablation of liver tumors. J Ultrasound Med 2001; 20: 517-23.
18. Bartolozzi C, Lencioni R, Ricci P, Paolicchi A, Rossi P, Passariello R. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. Radiology 1998; 209: 387-93.
19. Cioni D, Lencioni R, Rossi S et al. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power Doppler sonography to assess treatment outcome. AJR Am J Roentgenol 2001; 177: 783-8.
20. Meloni M, Goldberg SN, Livraghi T et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol 2001; 177: 375-80.
21. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30: 969-85.
22. Bauer A, Solbiati L, Weissman N. Ultrasound imaging with SonoVue: low mechanical index real-time imaging. Acad Radiol 2002; 9 (Suppl 2): 282-4.